Cholesterol Test Market Report 2026

Cholesterol Test Market Overview

• Cholesterol Test market size has reached to $9.94 billion in 2025 • Expected to grow to $15.25 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Cholesterol Test Market Driven By Increasing Prevalence Of Cardiovascular Diseases • Market Trend: Innovative Blood Testing Systems For Enhanced Cholesterol Monitoring And Preventive Healthcare • North America was the largest region in 2025.

What Is Covered Under Cholesterol Test Market?

A cholesterol test is an analysis of blood that measures the amount of cholesterol and other lipids in an individual's blood. Cholesterol is a waxy, fat-like molecule that body requires in small amounts for healthy health. The main types of cholesterol test products are test kits, test strips, and others. A test kit is a device that is used to monitor or detect a certain chemical residue or other attributes in a person, where people utilize cholesterol test kits at their leisure in a homecare setting to monitor cholesterol levels, eliminating the need for a visit to a healthcare center. The various test types are total cholesterol test, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides or very low-density lipoprotein (VLDL) cholesterol tests that are distributed via over-the-counter and prescription-based distribution channels by different end users such as hospitals, diagnostic centers, and others.

What Is The Cholesterol Test Market Growth Forecast?

The cholesterol test market size is expected to see strong growth in the next few years. It will grow to $15.25 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing demand for self-monitoring diagnostic tools, rising focus on early disease detection, expansion of remote patient testing solutions, growing integration of digital health platforms, increasing adoption of personalized healthcare diagnostics. Major trends in the forecast period include increasing adoption of home-based cholesterol testing kits, rising demand for point-of-care lipid testing devices, growing use of multi-parameter lipid panels, expansion of preventive cardiovascular screening programs, enhanced focus on rapid and accurate test results.

Global Cholesterol Test Market Segmentation

1) By Product Type: Test Kits, Test Strips, Other Product Types 2) By Test Type: Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) Cholesterol, Triglycerides Or Very Low-Density Lipoprotein (VLDL) Cholesterol Test 3) By Distribution Channel: Over The Counter, Prescription Based 4) By End User: Hospitals, Diagnostic Centers, Other End-Users Subsegments: 1) By Test Kits: Home Testing Kits, Laboratory Testing Kits 2) By Test Strips: Disposable Test Strips, Multi-Use Test Strips 3) By Other Product Types: Point-Of-Care Testing Devices, Cholesterol Monitors, Reagents And Calibration Solutions

What Is The Driver Of The Cholesterol Test Market?

The rise in the prevalence of cardiovascular diseases is expected to propel the growth of the cholesterol test market. Cardiovascular diseases (CVDs) are a category of heart and blood vessel disorders, including coronary heart disease, stroke, peripheral arterial disease, aortic disease, and other conditions. A cholesterol test provides individuals and doctors with vital information about the chance of developing heart disease. For instance, in August 2025, according to the National Institutes of Health, a US-based government agency, between 2025 and 2050, cardiovascular prevalence is projected to rise by 90%, mortality by 73%, and DALYs by 55%, with deaths increasing from 20.5 million to 35.6 million. Therefore, rising death and the prevalence of cardiovascular diseases will drive the cholesterol test industry.

Key Players In The Global Cholesterol Test Market

Major companies operating in the cholesterol test market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers GmbH, Fujifilm Holdings Corporation, CVS Health Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Mindray Medical International Limited, SYNLAB International GmbH, Beckman Coulter Inc., PerkinElmer Inc., Horiba Ltd., Sigma-Aldrich Corp, Randox Laboratories Ltd., Nova Biomedical Corp, Abcam plc, Sinocare Inc., ACM Global Laboratories, Clinical Reference Laboratory Inc., Sekisui Diagnostics LLC, Everlywell Inc., SpectraCell Laboratories Inc., LetsGetChecked USA, Ulta Lab Tests LLC, Cell Biolabs Inc., BioReference Health LLC, Diazyme Laboratories Inc.

Global Cholesterol Test Market Trends and Insights

Major companies operating in the cholesterol test market are focusing on developing innovative solutions, such as blood testing system, to enhance early detection and monitoring of cholesterol levels, improve patient outcomes, enable personalized treatment strategies, and support preventive healthcare initiatives. A blood testing system is a comprehensive setup or platform used to analyze blood samples for various components, markers, or conditions. For instance, in March 2024, Babson Diagnostics, Inc., an Austrelia-based healthcare technology startup, launched the BetterWay system, an innovative blood testing solution that includes the MiniDraw device for fingertip sample collection. The system warms the patient’s hand, collects a pea-sized blood sample via a lancet-equipped device, and automates sample preparation, including mixing and temperature regulation, before sending it to Babson’s lab for analysis. BetterWay can measure cholesterol, blood cell counts, and liver, kidney, and thyroid function from minimal blood, delivering results in one to two days while improving patient comfort and convenience. This approach bridges the gap between traditional lab-based testing and point-of-care accessibility, enhancing routine cholesterol monitoring.

What Are Latest Mergers And Acquisitions In The Cholesterol Test Market?

In January 2023, SD Biosensor, Inc., a South Korea-based company operating in diagnostics reagents, and SJL Partners, a Korea-based private equity investment, acquired Meridian Bioscience, Inc. for $1.53 billion. Through this acquisition, Meridian Bioscience, Inc aims to improve its capacity to service customers in diagnostics testing demand and develop new solutions using SDB's industry experience and complementary capabilities. Meridian Bioscience Inc is a US-based life science firm that manufactures, markets, and sells novel diagnostic devices in cholesterol and cardiac.

Regional Outlook

North America was the largest region in the cholesterol test market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cholesterol Test Market?

The cholesterol test market includes revenues earned by entities by providing various services such as clinical laboratory testing, online lab tests, medical advice, and diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The cholesterol test market also consists of sales of handheld point-of-care testing (POCT) devices, automated analyzers, lancets, and capillaries. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cholesterol Test Market Report 2026?

The cholesterol test market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cholesterol test industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.